Advertisement

Reactions Weekly

, Volume 1753, Issue 1, pp 86–86 | Cite as

Cabergoline

Various toxicities: 2 case reports
Case report
  • 6 Downloads

Reference

  1. Huang HY, et al. Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas. Endocrine 62: 464-469, No. 2, Nov 2018. Available from: URL: http://doi.org/10.1007/s12020-018-1702-5 - China

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations